32909-56-1

Upstream product

• 63-91-2 L-phenylalanine 
• 3282-30-2 pivaloyl chloride 

Downstream Products

• 95878-03-8 Tyr-Gly-Acc⁵-Phe-Leu-NH₂ 
• 95852-71-4 H-Tyr-Aib-Aib-Phe-Leu-NH₂ 
• 95852-70-3 Tyr-Gly-Aib-Phe-Leu-NH₂ 
• 95852-52-1 Acc⁵-Phe-Leu-NH₂ 
• 95852-51-0 Aib-Phe-Leu-NH₂ 
• 38678-59-0 L-Phe-L-Leu-NH₂ 
• 102522-56-5 (2S,4S,5S)-5-[(S)-2-[(S)-2-(2,2-Dimethyl-propionylamino)-3-phenyl-propionylamino]-3-(1H-imidazol-4-yl)-propionylamino]-4-hydroxy-2-isopropyl-7-methyl-octanoic acid {(1S,2S)-1-[(S)-1-carbamoyl-2-(1H-imidazol-4-yl)-ethylcarbamoyl]-2-methyl-butyl}-amide 
• 102522-55-4 Piv-Phe-His-OH 
• 102522-57-6 Piv-Phe-His-OMe 

Relevant academic research and scientific papers

HIV protease inhibitors based on amino acid derivatives

A compound selected from the group consisting of a compound of formula I 1a compound of formula II 2and when the compound of formula I and II comprises an amino group pharmaceutically acceptable ammonium salts thereof, wherein R1, R2, Cx, n, R3, R4, R5, Y are as defined in the specification.

SUBSTITUTED 5-AMINO-4-HYDROXYVALERYL DERIVATIVES

Compounds of the formula STR1 in which R 1 represents hydrogen or acyl, X 1 represents an optionally N-alkylated amino acid residue that is bonded N-terminally to R 1 and C-terminally to X 2, X 2 represents an optionally N-alkylated amino acid residue tha